Adenoid Vegetations in Adult Patients

April 6, 2024 updated by: Varazdin General Hospital

The Clinical Characteristics of Adenoid Vegetations in Adult Patients

In this observational cross-sectional study " the clinical characteristics of adenoid vegetations in adulthood will be investigated.

Study Overview

Status

Completed

Conditions

Detailed Description

Adenoid vegetations typically appear in childhood and are well described in this population. However, in adulthood, adenoid vegetations appear rarely and their characteristics have not been described.

The clinical characteristics of adenoid vegetations in adulthood will be investigated, and compared with clinical characteristics of adenoid vegetations in childhood.

Study Type

Observational

Enrollment (Actual)

161

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Croatia
      • Varazdin, Croatia, 42000
        • Varazdin General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult group: All patients aged 14 and more treated for adenoid vegetations in Varazdin General Hospital from 1 January 2013 to 31 December 2019

Children group: All patients aged 13 and less treated for adenoid vegetations in Varazdin General Hospital from 1 January 2019 to 31 December 2019

Description

Inclusion Criteria:

  • patient with adenoid vegetations

Exclusion Criteria:

  • other concomitant otorhinolaryngological diagnoses
  • hypertrophy of the tonsils
  • oropharyngeal carcinomas
  • chronic sinuitis
  • allergic rhinitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Adults
Patients with adenoid vegetations, 14 years old and older
Children
Patients with adenoid vegetations, 13 years old and younger

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptoms
Time Frame: 2 months
The leading symptom (patient's main complaint, the reason for seeing the doctor) will we recorded for each participant
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of symptoms
Time Frame: 2 months
The duration of leading symptom (in months) will be recorded for each participant
2 months
OTS (otoscopic)
Time Frame: 2 months
The otoscopic findings will be recorded in both groups
2 months
RNS (rhinoscopic)
Time Frame: 2 months
The rhinoscopic findings will be recorded in both groups
2 months
OFS (oropharyngoscopic)
Time Frame: 2 months
The oropharyngoscopic findings will be recorded in both groups
2 months
PRNS (post-rhynoscopic)
Time Frame: 2 months
The post-rhynoscopic findings will be recorded in both groups
2 months
Referring physician
Time Frame: 2 months
The physician (primary or secondary level) who referred the patient to ENT (Ear Nose and Throat doctor) will be recorded in both groups
2 months
PHD ( pathohistological findings)
Time Frame: 2 months
The pathohistological findings will be recorded in both groups
2 months
Surgery
Time Frame: 2 months
The type of surgery will be recorded in both groups
2 months
Outcome
Time Frame: 2 months
The outcome (the relief of the leading symptom) will be recorded in both groups
2 months
Recurrence
Time Frame: 2 months
The recurrence will be recorded in both groups
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Varazdin General Hospital

Investigators

  • Principal Investigator: Drazen Shejbal, Varazdin General Hospital, Varazdin, Croatia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2023

Primary Completion (Actual)

December 31, 2023

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

September 5, 2023

First Submitted That Met QC Criteria

September 13, 2023

First Posted (Actual)

September 18, 2023

Study Record Updates

Last Update Posted (Actual)

April 9, 2024

Last Update Submitted That Met QC Criteria

April 6, 2024

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 1968

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adenoid Vegetation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe